Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Avoid exposing the patient to the risks of radiation
Ntoco promotes ferroptosis via Hnrnpab-mediated NF-B/Lcn2 axis following traumatic brain injury in mice
S7C and S7F)
Composition DSIP: 15 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment via HPLC/LC-MS Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Manufactured in the USA in an ISO 9001based, cGMP-aligned facility COA pending third-party verification in progress Lyophilized for transit stability
It is considered an experimental compound and therefore the decision is made between you and your doctor whether this is the right treatment for you
